Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 11 (RN7SKP11) is classified as a pseudogene, specifically a pseudogenic copy of the 7SK small nuclear RNA gene (RN7SK)[3][5]. Pseudogenes are generally non-functional remnants of genes that have lost their protein-coding ability or are otherwise non-expressed due to mutations. Unlike protein-coding genes or functional non-coding RNAs, pseudogenes like RN7SKP11 are not known to be involved in specific biological processes, do not encode protein or functional RNA, and are not recognized as therapeutic targets, receptors, or enzymes[3][5]. No diseases, functions, interacting drugs, or safety considerations have been associated with RN7SKP11. RN7SKP11 is documented in authoritative gene databases such as GeneCards and NCBI Gene, where it is explicitly categorized as a pseudogene[3][5]. It should not be confused with the functional 7SK small nuclear RNA gene RN7SK, which has established regulatory roles in transcription and cellular processes[1][2][6]. As a pseudogene, RN7SKP11 has no known biological function and is not a therapeutic target. It does not participate in recognized molecular families like receptors, enzymes, or channels[3][5]. No clinical or research literature describes any disease role, drug interaction, biomarker usage, or safety issues specific to RN7SK pseudogene 11[3][5]. RN7SKP11 is a pseudogene and not an active molecular target. No evidence indicates errors in the synonymy or identification of this entry. No evidence supports its role in disease, drug interaction, or therapeutic development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 11 (RN7SKP11).